PL359357A1 - Związki indolinowe, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne - Google Patents

Związki indolinowe, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne

Info

Publication number
PL359357A1
PL359357A1 PL03359357A PL35935703A PL359357A1 PL 359357 A1 PL359357 A1 PL 359357A1 PL 03359357 A PL03359357 A PL 03359357A PL 35935703 A PL35935703 A PL 35935703A PL 359357 A1 PL359357 A1 PL 359357A1
Authority
PL
Poland
Prior art keywords
compounds
manufacture
pharmaceutical compositions
compositions containing
indoline
Prior art date
Application number
PL03359357A
Other languages
English (en)
Other versions
PL208281B1 (pl
Inventor
Gilbert Lavielle
Olivier Muller
Mark Millan
Alain Gobert
Original Assignee
Les Laboratoires Servier
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Les Laboratoires Servier filed Critical Les Laboratoires Servier
Publication of PL359357A1 publication Critical patent/PL359357A1/pl
Publication of PL208281B1 publication Critical patent/PL208281B1/pl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
    • C07D401/12—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a chain containing hetero atoms as chain links
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/14—Prodigestives, e.g. acids, enzymes, appetite stimulants, antidyspeptics, tonics, antiflatulents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/08—Drugs for genital or sexual disorders; Contraceptives for gonadal disorders or for enhancing fertility, e.g. inducers of ovulation or of spermatogenesis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/10—Drugs for genital or sexual disorders; Contraceptives for impotence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/06—Antimigraine agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/14—Drugs for disorders of the nervous system for treating abnormal movements, e.g. chorea, dyskinesia
    • A61P25/16—Anti-Parkinson drugs
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/20—Hypnotics; Sedatives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/26—Psychostimulants, e.g. nicotine, cocaine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Organic Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Reproductive Health (AREA)
  • Psychiatry (AREA)
  • Endocrinology (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Gynecology & Obstetrics (AREA)
  • Pain & Pain Management (AREA)
  • Anesthesiology (AREA)
  • Hospice & Palliative Care (AREA)
  • Psychology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Nutrition Science (AREA)
  • Pregnancy & Childbirth (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Indole Compounds (AREA)
PL359357A 2002-03-27 2003-03-26 Związki indolinowe, sposób ich wytwarzania oraz zawierająca je kompozycja farmaceutyczna PL208281B1 (pl)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
FR0203788A FR2837823B1 (fr) 2002-03-27 2002-03-27 Nouveaux derives d'indoline, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Publications (2)

Publication Number Publication Date
PL359357A1 true PL359357A1 (pl) 2003-10-06
PL208281B1 PL208281B1 (pl) 2011-04-29

Family

ID=8871507

Family Applications (1)

Application Number Title Priority Date Filing Date
PL359357A PL208281B1 (pl) 2002-03-27 2003-03-26 Związki indolinowe, sposób ich wytwarzania oraz zawierająca je kompozycja farmaceutyczna

Country Status (24)

Country Link
US (2) US6759421B2 (pl)
EP (1) EP1348704B1 (pl)
JP (1) JP3926284B2 (pl)
KR (1) KR100562207B1 (pl)
CN (1) CN1209359C (pl)
AR (1) AR039145A1 (pl)
AT (1) ATE326457T1 (pl)
AU (1) AU2003203287B2 (pl)
BR (1) BR0300759A (pl)
CA (1) CA2423820C (pl)
CY (1) CY1105509T1 (pl)
DE (1) DE60305229T2 (pl)
DK (1) DK1348704T3 (pl)
EA (1) EA005620B1 (pl)
ES (1) ES2263927T3 (pl)
FR (1) FR2837823B1 (pl)
HK (1) HK1057368A1 (pl)
MX (1) MXPA03002532A (pl)
NO (1) NO324761B1 (pl)
NZ (1) NZ524958A (pl)
PL (1) PL208281B1 (pl)
PT (1) PT1348704E (pl)
SI (1) SI1348704T1 (pl)
ZA (1) ZA200302392B (pl)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101005534B1 (ko) * 2008-06-23 2011-01-04 (주)핼릭스케어 충격 흡수력이 우수한 인솔

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU4704693A (en) * 1992-08-20 1994-03-15 Smithkline Beecham Plc Condensed indole derivatives as 5HT-2C and 5HT-2B antagonists
GB9313913D0 (en) * 1993-07-06 1993-08-18 Smithkline Beecham Plc Novel compounds
JPH09512025A (ja) * 1994-04-23 1997-12-02 スミスクライン・ビーチャム・パブリック・リミテッド・カンパニー ５ｈｔ▲下２ｃ▼および５ｈｔ▲下２ｂ▼アンタゴニストとしての三環式誘導体
US6221884B1 (en) * 1997-06-04 2001-04-24 Eli Lilly And Company Carboxamides useful as 5-HT1F agonists
FR2807754A1 (fr) * 2000-04-13 2001-10-19 Adir Nouveaux derives de cyclobuta-indole carboxamide, leur procede de preparation et les compositions pharmaceutiques qui les contiennent

Also Published As

Publication number Publication date
JP3926284B2 (ja) 2007-06-06
KR20030078035A (ko) 2003-10-04
US6759421B2 (en) 2004-07-06
AR039145A1 (es) 2005-02-09
EP1348704B1 (fr) 2006-05-17
ES2263927T3 (es) 2006-12-16
NO20031371L (no) 2003-09-29
US7053108B2 (en) 2006-05-30
DE60305229T2 (de) 2007-05-24
BR0300759A (pt) 2004-09-14
EA200300302A1 (ru) 2003-10-30
CN1446813A (zh) 2003-10-08
AU2003203287B2 (en) 2008-08-28
US20030199555A1 (en) 2003-10-23
NO20031371D0 (no) 2003-03-26
DE60305229D1 (de) 2006-06-22
CA2423820A1 (fr) 2003-09-27
FR2837823A1 (fr) 2003-10-03
JP2004035541A (ja) 2004-02-05
NZ524958A (en) 2004-03-26
CN1209359C (zh) 2005-07-06
KR100562207B1 (ko) 2006-03-22
US20040192736A1 (en) 2004-09-30
PT1348704E (pt) 2006-08-31
CY1105509T1 (el) 2010-04-28
CA2423820C (fr) 2008-08-05
MXPA03002532A (es) 2004-09-06
SI1348704T1 (sl) 2006-08-31
EA005620B1 (ru) 2005-04-28
ZA200302392B (en) 2003-09-30
HK1057368A1 (en) 2004-04-02
FR2837823B1 (fr) 2005-04-08
DK1348704T3 (da) 2006-09-25
AU2003203287A1 (en) 2003-10-23
PL208281B1 (pl) 2011-04-29
EP1348704A1 (fr) 2003-10-01
NO324761B1 (no) 2007-12-10
ATE326457T1 (de) 2006-06-15

Similar Documents

Publication Publication Date Title
IL190218A0 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
HK1086485A1 (en) Novel compounds, pharmaceutical compositions containing same, and methods of use for same
AU2003239302A1 (en) Aminopiperidine compounds, process for their preparation, and pharmaceutical compositions containing them
IS7543A (is) Bensóþíadíasepínafleiður, aðferðir til framleiðslu þeirra og lyfjablöndur sem innihalda þær
IL163831A0 (en) Derivatives of aminoindazoles, method of preparation and intermediates of the method as drugs pharmaceutical compounds containing
AU2002363236A1 (en) Compounds, pharmaceutical compositions and methods of use therefor
GB0321607D0 (en) Manufacture of pharmaceutical compositions
IL173930A0 (en) Pharmaceutical compositions containing forms of r-baclofen
HK1090042A1 (en) Substituted 4-phenyltetrahydroisoquinolines, method for the production thereof, the of the same as medicaments, and medicament containing such compounds
PL380851A1 (pl) Nowe pochodne pirydynowe, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
IL164424A0 (en) Novel perindopril, salt and pharmaceutical compositions containing same
IL166621A0 (en) Polymorph of n-methyl-n-(3-ä-3-Ä2-thienylcarbonylÜ-pyrazol-Ä1,5-alphaÜpyrimidin-7-ylüacetamide and pharmaceutical compositions containing the same
IS7424A (is) Oxasólídínónafleiður, aðferðir til að framleiða þær og lyfjablöndur sem innihalda þær
HUP0203976A3 (en) Adenozine a3 receptors, process for their preparation and pharmaceutical compositions containing them
AU2003231920A8 (en) Antiinfectve compounds, process for their preparation and pharmaceutical compositions containing them
HUP0401082A3 (en) Substituted 4-aminocyclohexanols, process for their preparation and pharmaceutical compositions containing them
AU2002306687A1 (en) Heterocyclic compounds, process for their preparation and pharmaceutical compositions containing them
HUP0400207A3 (en) Substituted 4-aminocyclohexanol derivatives, process for their preparation and pharmaceutical compositions containing them
HUP0201024A3 (en) Izoindeindolone compounds, process for their preparation and pharmaceutical compositions containing them
AU2003270202A8 (en) Pharmaceutical compositions useful for the treatment of cancers
PL394208A1 (pl) Nowe pochodne benzo[g]chinoliny, kompozycje farmaceutyczne je zawierające oraz zastosowania farmaceutyczne tych związków
PL359357A1 (pl) Związki indolinowe, sposób ich wytwarzania oraz zawierające je kompozycje farmaceutyczne
HK1084112A1 (en) Substituted benzolÄeÜÄ1,4ÜoxazinoÄ3,2-gÜisoindole derivatives, method for preparing same and pharma ceutical compositions containing same
PL358033A1 (pl) Fenylobenzamidynowe pochodne 3-metylo-5-amino-4-karboksyizotiazolu, sposób ich wytwarzania i zawierające je środki farmaceutyczne
HUP0302440A3 (en) Aminoquinoline derivatives, process for producing them and pharmaceutical compositions containing them

Legal Events

Date Code Title Description
LAPS Decisions on the lapse of the protection rights

Effective date: 20120326